• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国云南多民族人群扩大携带者筛查的诊断率

Diagnostic yield of expanded carrier screening of a multi-ethnic population in yunnan, China.

作者信息

Wang Huizi, Zhao Quxi, Xie Dongping, Peng Jinbi, Chen Guixian, Dong Xudong

机构信息

The Obstetrical Department, The First People's Hospital of Yunnan Province, No. 157 Jinbi Road, Xishan District, Kunming, 650032, Yunnan Province, China.

The Obstetrical Department, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.

出版信息

Sci Rep. 2025 Jul 2;15(1):23590. doi: 10.1038/s41598-025-08012-3.

DOI:10.1038/s41598-025-08012-3
PMID:40604033
Abstract

Rare genetic diseases are responsible for a small but significant proportion of childhood morbidity and mortality. The majority of these diseases have no treatment and they create a huge burden on the families and the whole society. A well-tested strategy to prevent these diseases from happening is carrier screening, which can reduce the incidents of autosomal recessive (AR) and X-linked (XL) conditions. Using a carrier screening panel based on next-generation sequencing, 1265 patients including 388 pairs of couples were tested for 486 genes, covering 623 conditions. A total of 1397 variants were found in 66.32% of the individuals, representing a mutation burden of 1.10 variants per person. The highest mutation burdens were found in the subgroups participants with histories of abnormal pregnancies (1.38), health issues (1.34), and ultrasound anomalies(1.23), respectively. Among the 388 pairs of couples, 19 pairs were found to be at high risk of having a child affected by either AR (9 pairs) or XL (10 pairs) conditions. DUOX2, HBA1/2, and USH2A were the most frequently mutated genes found. A cutoff gene frequency of over 1/200 as recommended by ACMG in this study would include the top 20 genes and cover 37.94% of all the variants identified. Ten couples with fertility risk were followed up on their subsequent reproductive choices and intervention, including to choose IVF, abortion and keep the affected child. Given that most individuals carried 1 or 2 variants in this population, carrier screening programs seem to be a worthy investment as a public health tool. Patient follow-ups demonstrated that couples in China have diverse opinions and values regarding reproductive choices.

摘要

罕见遗传病在儿童发病率和死亡率中所占比例虽小但意义重大。这些疾病大多无法治疗,给家庭和整个社会带来了巨大负担。一种经过充分验证的预防这些疾病发生的策略是携带者筛查,它可以减少常染色体隐性(AR)和X连锁(XL)疾病的发生率。使用基于下一代测序的携带者筛查面板,对1265名患者(包括388对夫妇)进行了486个基因的检测,涵盖623种疾病。在66.32%的个体中总共发现了1397个变异,每人的突变负担为1.10个变异。在有异常妊娠史(1.38)、健康问题(1.34)和超声异常(1.23)的亚组参与者中发现了最高的突变负担。在388对夫妇中,发现有19对夫妇生育受AR(9对)或XL(10对)疾病影响孩子的风险较高。DUOX2、HBA1/2和USH2A是最常发现的突变基因。本研究中美国医学遗传学与基因组学学会(ACMG)推荐的超过1/200的截止基因频率将包括前20个基因,覆盖所有已鉴定变异的37.94%。对10对有生育风险的夫妇的后续生殖选择和干预进行了跟踪,包括选择体外受精、堕胎和留下患病儿童。鉴于该人群中的大多数个体携带1个或2个变异,携带者筛查计划作为一种公共卫生工具似乎是一项值得投资之举。患者随访表明,中国夫妇在生殖选择方面有不同的观点和价值观。

相似文献

1
Diagnostic yield of expanded carrier screening of a multi-ethnic population in yunnan, China.中国云南多民族人群扩大携带者筛查的诊断率
Sci Rep. 2025 Jul 2;15(1):23590. doi: 10.1038/s41598-025-08012-3.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
10
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.

本文引用的文献

1
Genetic analysis of albinism caused by compound heterozygous mutations of the OCA2 gene in a Chinese family.一个中国家庭中由OCA2基因复合杂合突变引起的白化病的遗传学分析。
Hereditas. 2024 Feb 6;161(1):8. doi: 10.1186/s41065-024-00312-4.
2
Carrier burden of over 300 diseases in Han Chinese identified by expanded carrier testing of 300 couples using assisted reproductive technology.通过对 300 对接受辅助生殖技术的夫妇进行扩展携带者检测,鉴定出汉族人群中超过 300 种疾病的携带者负担。
J Assist Reprod Genet. 2023 Sep;40(9):2157-2173. doi: 10.1007/s10815-023-02876-y. Epub 2023 Jul 14.
3
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG SF v3.2 临床外显子组和基因组测序中报告次要发现的列表:美国医学遗传学与基因组学学会 (ACMG) 的政策声明。
Genet Med. 2023 Aug;25(8):100866. doi: 10.1016/j.gim.2023.100866. Epub 2023 Jun 22.
4
Clinical application value of expanded carrier screening in the population of childbearing age.生育年龄段人群扩展携带者筛查的临床应用价值。
Eur J Med Res. 2023 Apr 8;28(1):151. doi: 10.1186/s40001-023-01112-8.
5
Expanded carrier screening for reproductive risk assessment: An evidence-based practice guideline from the National Society of Genetic Counselors.扩展携带者筛查用于生殖风险评估:来自国家遗传咨询师协会的循证实践指南。
J Genet Couns. 2023 Jun;32(3):540-557. doi: 10.1002/jgc4.1676. Epub 2023 Feb 9.
6
Clinical Utility of Medical Exome Sequencing: Expanded Carrier Screening for Patients Seeking Assisted Reproductive Technology in China.医学外显子组测序的临床应用:中国接受辅助生殖技术患者的扩展携带者筛查
Front Genet. 2022 Aug 22;13:943058. doi: 10.3389/fgene.2022.943058. eCollection 2022.
7
Current Updates on Expanded Carrier Screening: New Insights in the Omics Era.现行扩展携带者筛查的最新进展:组学时代的新见解。
Medicina (Kaunas). 2022 Mar 21;58(3):455. doi: 10.3390/medicina58030455.
8
Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review.生殖载体筛查隐性遗传疾病的经济评价:系统综述。
Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):197-206. doi: 10.1080/14737167.2022.1993063. Epub 2021 Oct 26.
9
Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG).妊娠期和孕前筛查常染色体隐性和 X 连锁疾病:美国医学遗传学与基因组学学会(ACMG)实践资源。
Genet Med. 2021 Oct;23(10):1793-1806. doi: 10.1038/s41436-021-01203-z. Epub 2021 Jul 20.
10
Reproductive carrier screening: responding to the eugenics critique.生殖载体筛查:回应优生学批判。
J Med Ethics. 2022 Dec;48(12):1060-1067. doi: 10.1136/medethics-2021-107343. Epub 2021 Jul 9.